Dr. Reddy's Laboratories Ltd . 8-2-337, Road No. 3, Banjara Hills Hyderabad - 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

This is in reference to our intimation dated May 24, 2025, wherein we had informed regarding the GMP inspection conducted by the United States Food & Drug Administration (USFDA) at our API manufacturing facility (CTO 5) in Miryalaguda, Telangana, India.

We wish to inform you that the Company has received the Establishment Inspection Report (EIR) on August 7, 2025. The USFDA has classified the inspection outcome as 'Voluntary Action Indicated (VAI)' and concluded that the inspection is officially closed under 21 CFR 20.64(d)(3).

This is for your information and record.

For Dr. Reddy's Laboratories Limited

Company Secretary, Compliance Officer & Head-CSR